phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
Published 1 year ago • 50 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:06
phase ib/ii study of viro-t-cell in patients with r/r cml infection after allosct
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
2:11
addressing the issue of resistance to tkis in cml
-
3:54
preventative maintenance on the bd facsvia™ system
-
![new method for standardized pbmc isolation for observational and clinical studies [webinar]](https://i.ytimg.com/vi/nFw-R9LJztA/mqdefault.jpg)
30:40
new method for standardized pbmc isolation for observational and clinical studies [webinar]
-
17:41
for myelofibrosis patients: the latest on promising treatments from top specialist | dr. ruben mesa
-
2:33
btki resistance and it's management
-
1:49
phase ii trial-in-progress of itacitinib in patients with myelofibrosis
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:40
targeting tki-resistant cml with ly3009120 and asciminib
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
8:56
module 2 1